secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibrx Biosciences, Inc. (INBX)
CIK:        0002007919
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001104659-24-065140
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inhibrx Biosciences spin-off registration effective; distribution May 29, merger with Sanofi May 30
--------------------------------------------------------------------------------

- Registration statement on Form 10 declared effective by SEC on May 24, 2024.
- Distribution of 92% of Inhibrx Biosciences shares to RemainCo holders at 1:4 ratio; effective May 29.
- RemainCo merger with Sanofi expected to close May 30, subject to conditions.
- When-issued trading under INXBV from May 28; regular-way under INXB from May 30; then INBX from May 31.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2007919/000110465924065140/0001104659-24-065140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2007919/000110465924065140/tm243190d17_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-065140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer